Stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Comply with the "Guidelines for the Diagnosis and Treatment of Stroke" and diagnosed as stroke with upper limb motor dysfunction by MRI or CT. (2) Upper limb muscle tone modified Ashworth scale rating of ?1+. (3) First episode, or no residual upper extremity motor dysfunction after the last episode. (4) No gender restrictions, aged 18-80 years old, with a duration of ischaemic stroke from 2 weeks to 6 months and haemorrhagic stroke from 1 month to 6 months. (5) No severe cognitive impairment, aphasia, or hearing loss. (6) No physical disability, motor dysfunction, or sensory dysfunction prior to the onset of stroke. (7) Willing to participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with cranial defects in the affected hemisphere, subarachnoid haemorrhage, cavernous cerebral infarction, brain tumour, cerebral aneurysm, traumatic brain injury, etc., as well as patients with severe hydrocephalus, large cerebral haematoma, and patients with deterioration of the condition during the progressive stage of stroke. (2) With serious diseases of heart, lungs, liver, kidney and other internal organs, unable to tolerate the treatment. (3) Previous motor dysfunction caused by other diseases, such as multiple sclerosis, myasthenia gravis, etc. (4) Have a history or family history of seizures, or are taking medications that lower the seizure threshold or antiepileptic drugs. (5) Metal foreign bodies in the skull, face, cervical spine, or around the clavicle on the affected side. (6) Have an implanted electronic device such as a pacemaker, cochlear implant, or related medical pumps. (7) Recent severe headache or frequent headache (8) Female subjects who are pregnant, breastfeeding, or likely to become pregnant. (9) Participated or is participating in other intervention studies in the last week
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper Extremity Section of the Fugl-Meyer Scale (FMA-UE); | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Barthel Index (MBI);Motor Assessment Scale (MAS);functional near-infrared spectroscopy,fNIRS; | — |
Countries
China
Contacts
Department of Rehabilitation Medicine, Golden Hospital, The First Affiliated Hospital of Gannan Medical University, Ganzhou City, Jiangxi Province, China